US Dollar vs MXN

Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

Regístrate

AADI Aadi Bioscience Inc

1.81

-0.01 (-0.55%)

24 May 2024 - Cerrado

Retrasado por 15 minutos

Form 3 - Initial statement of beneficial ownership of securities

Aadi Bioscience (NASDAQ:AADI)
Gráfica de Acción Histórica
De Abr 2024 a May 2024

Haga Click aquí para más Gráficas Aadi Bioscience.

Aadi Bioscience (NASDAQ:AADI)
Gráfica de Acción Histórica
De May 2023 a May 2024

Haga Click aquí para más Gráficas Aadi Bioscience.

Noticias sobre Aadi Bioscience Inc AADI

Aadi Bioscience Presents New Nonclinical Data Demonstrating Preferential Tumor Uptake of nab-Sirolimus at the American Society of Clinical Oncology (ASCO) Annual Meeting
Jueves 23 de Mayo 2024 (4 días hace) • PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Miércoles 8 de Mayo 2024 (3 semanas hace) • Edgar (US Regulatory)

Form 8-K - Current report
Miércoles 8 de Mayo 2024 (3 semanas hace) • Edgar (US Regulatory)

Aadi Bioscience Announces Financial Results for the First Quarter 2024 and Provides Corporate Update
Miércoles 8 de Mayo 2024 (3 semanas hace) • PR Newswire (US)

Aadi Bioscience to Report First Quarter 2024 Results and Corporate Update
Miércoles 1 de Mayo 2024 (4 semanas hace) • PR Newswire (US)

Aadi Bioscience to Present New Non-clinical Data Highlighting Combinability of nab-Sirolimus at the American Association for Cancer Research (AACR) Annual Meeting
Martes 9 de Abril 2024 (2 meses hace) • PR Newswire (US)

Aadi Bioscience Presents New Subgroup Analysis of Patients with Advanced Malignant PEComa of Gynecologic Origin Treated with nab-Sirolimus at Society of Gynecologic Oncology (SGO)
Domingo 17 de Marzo 2024 (2 meses hace) • PR Newswire (US)

Aadi Bioscience Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Corporate Update
Miércoles 13 de Marzo 2024 (2 meses hace) • PR Newswire (US)

Aadi Bioscience to Report Fourth Quarter and Full-Year 2023 Results and Corporate Update
Miércoles 6 de Marzo 2024 (3 meses hace) • PR Newswire (US)

Aadi Bioscience to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024
Martes 5 de Marzo 2024 (3 meses hace) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Lunes 4 de Marzo 2024 (3 meses hace) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Lunes 4 de Marzo 2024 (3 meses hace) • Edgar (US Regulatory)

Más de Aadi Bioscience Inc Artículos de Noticias

Royal Bank of Canada Aut...

Societe Generale Effekten

Medirect Latino (CE)

Discovery Alaska

Nat.grd.e.swl36

Natwest Mk5.625

Gryphon Minerals

BlackRock Institutional ...

Mound Fin.4 4cs

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones